Logotype for T1 Energy Inc

T1 Energy (TE) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for T1 Energy Inc

Q4 2025 earnings summary

7 Apr, 2026

Executive summary

  • Achieved record Q4 2025 production and sales at G1_Dallas, with 1.13 GW produced in Q4 and 2.79 GW for the year, surpassing previous quarters and meeting annual targets.

  • Construction of G2_Austin solar cell fab is on schedule, with Phase 1 targeting 2.1 GW capacity, first steel erection expected in April, and production set for Q4 2026.

  • Secured major supply and offtake agreements, including a three-year, 900 MW contract with Treaty Oak Clean Energy and expanded partnerships with Hemlock Corning and Nextpower.

  • Raised over $440 million in Q4 2025 through equity and convertible offerings, enhancing liquidity and supporting G2_Austin development.

  • Completed first sale of $160 million in Section 45X tax credits at $0.91 per dollar to a U.S. financial institution.

Financial highlights

  • 2025 net sales reached $755.3 million, with Q4 net sales of $358.6 million, nearly matching the total of the first three quarters.

  • Gross margin for 2025 was 7.4%, with gross profit of $55.6 million.

  • Adjusted EBITDA for 2025 was $(65.0) million, impacted by non-recurring items including a $34 million sales commission waiver and $16 million inventory sale at lower prices.

  • Year-end 2025 cash, equivalents, and restricted cash totaled $270.8 million, with $182.5 million unrestricted.

  • Full-year 2025 net loss attributable to stockholders was $380.8 million ($2.19 per share), improved from $450.2 million in 2024.

Outlook and guidance

  • 2026 production and sales guidance maintained at 3.1–4.2 GW, with 3 GW already contracted and confidence in reaching the high end.

  • Upon completion of G2_Austin Phase 1, annualized run-rate Adjusted EBITDA expected at $375–$450 million in 2027; full G1/G2 (Phases 1–2) projected at $650–$700 million.

  • Expecting improved margin performance and sequential ramp in sales and EBITDA throughout 2026.

  • G2_Austin Phase 1 to be fully funded by April, with high-efficiency domestic cell production by year-end 2026.

  • 2026 seen as a bridge year, with a step change in earnings and cash flow anticipated in 2027.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more